Rabeprazole Sodium Market is expand at a CAGR of 4.8% to reach USD 984 million by 2032 – Cipla Ltd, Cadila Pharmaceuticals Ltd, Alembic Pharmaceuticals Ltd, Woodward Pharma, Elikem Pharmaceuticals Pvt Ltd

The global rabeprazole sodium market was valued at USD 615.7 billion in 2022 and it is anticipated to grow further till USD 984 million by 2032, at a CAGR of 4.8% during the forecast period.

Rabeprazole is used to treat duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease (GERD). In addition, it can be used in conjunction with medications to treat ulcers caused by H. pylori bacterial infections (such as amoxicillin and clarithromycin). Rabeprazole, a proton pump inhibitor (PPI), lessens the amount of stomach acid produced. It inhibits the gastric H+/K+ATPase (hydrogen-potassium adenosine triphosphatas) at the secretory surface of the gastric parietal cell.

To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS24641

Market Trends and Drivers

Rabeprazole lessens the quantity of stomach acid production. It is frequently used to treat gastroesophageal reflux disease, acid reflux, and heartburn. Acid reflux that occurs repeatedly is known as GORD. Rabeprazole can also be used to treat and prevent stomach ulcers. Therefore, the market is growing as digestive issues become more common. GORD is one of the most prevalent gastrointestinal illnesses, affecting 20% of individuals in western societies, according to the National Library of Medicine.

According to El-Serag et alsystematic .’s review, GERD prevalence in the US ranges from 18.1% to 27.8%. Therefore, the industry for rabeprazole sodium is driven by the rise in digestive system problems.

Get A Customized Scope to Match, Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS24641

Global Rabeprazole Sodium Market Segmentation

By Application

  • Gastroesophageal Reflux Disease
  • Peptic Ulcer
  • Others

By Age

  • Below 55 Years
  • Above 55 Years

By Distribution Channel

  • Hospital Pharmacies
  • Drug & Retail Store Pharmacies
  • Online Providers

For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/checkout/single_user/GIS24641

Major Players in the Global Rabeprazole Sodium Market

The key players studied the report are Cipla Ltd, Cadila Pharmaceuticals Ltd, Alembic Pharmaceuticals Ltd, Woodward Pharma, Elikem Pharmaceuticals Pvt Ltd, Sun Pharmaceutical Industries Ltd., Jasco Labs Private Limited, Torrent Pharmaceuticals Ltd, Intas Pharmaceutical, Ltd., Dr. Reddy’s Laboratories Ltd among others.

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

%d bloggers like this: